Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

FENC

Fennec Pharmaceuticals Inc

May 12 • 04:00PM ET

7.03

-0.07 -0.99 %

Healthcare • Biotechnology • USA • Micro • NASD

Peers: NVCT ORIC ADCT KPTI VERU

| Held by: VTI IWM IWN VTWO IWC IWO OMFS VTWV RSSL VTWG

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-0.34	Insider Own	14.47%	Shs Outstand	34.16M	Perf Week	4.61%
Market Cap	242.82M	Forward P/E	8.33	EPS next Y	0.84	Insider Trans	-21.09%	Shs Float	29.49M	Perf Month	18.55%
Enterprise Value	206.03M	PEG	-	EPS next Q	-0.04	Inst Own	60.75%	Short Float	3.60%	Perf Quarter	-9.76%
Income	-10.10M	P/S	5.44	EPS this Y	136.19%	Inst Trans	4.08%	Short Ratio	6.06	Perf Half Y	-11.90%
Sales	44.64M	P/B	6.77	EPS next Y	565.97%	ROA	-17.48%	Short Interest	1.06M	Perf YTD	-8.70%
Book/sh	1.04	P/C	6.60	EPS next 5Y	-	ROE	-68.24%	52W High	9.92 -29.13%	Perf Year	12.12%
Cash/sh	1.07	P/FCF	-	EPS past 3/5Y	27.71% 14.90%	ROIC	-28.47%	52W Low	5.65 24.42%	Perf 3Y	-6.39%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	207.52% 204.69%	Gross Margin	91.57%	Volatility	6.39% 5.52%	Perf 5Y	17.56%
Dividend TTM	-	EV/Sales	4.62	EPS Y/Y TTM	-12844.44%	Oper. Margin	-15.11%	ATR (14)	0.39	Perf 10Y	146.15%
Dividend Ex-Date	-	Quick Ratio	6.23	Sales Y/Y TTM	-6.09%	Profit Margin	-22.62%	RSI (14)	55.18	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	6.37	EPS Q/Q	-179.66%	SMA20	4.62%	Beta	0.93	Target Price	15.17
Payout	-	Debt/Eq	0.00	Sales Q/Q	73.84%	SMA50	2.40%	Rel Volume	0.65	Prev Close	7.10
Employees	35	LT Debt/Eq	0.00	Earnings	May 14 BMO	SMA200	-11.30%	Avg Volume	174.94K	Price	7.03
IPO	Oct 22, 2003	Option/Short	Yes / Yes	EPS/Sales Surpr.	-502.84% -6.49%	Trades		Volume	114,123	Change	-0.99%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)